Discovery and structural diversity of the hepatitis C virus NS3/4A serine protease inhibitor series leading to clinical candidate IDX320
作者:Christophe C. Parsy、François-René Alexandre、Valérie Bidau、Florence Bonnaterre、Guillaume Brandt、Catherine Caillet、Sylvie Cappelle、Dominique Chaves、Thierry Convard、Michel Derock、Damien Gloux、Yann Griffon、Lisa B. Lallos、Frederic Leroy、Michel Liuzzi、Anna-Giulia Loi、Laure Moulat、Musiu Chiara、Houcine Rahali、Virginie Roques、Elodie Rosinovsky、Simon Savin、Maria Seifer、David Standring、Dominique Surleraux
DOI:10.1016/j.bmcl.2015.09.009
日期:2015.11
Exploration of the P2 region by mimicking the proline motif found in BILN2061 resulted in the discovery of two series of potent HCV NS3/4A protease inhibitors. X-ray crystal structure of the ligand in contact with the NS3/4A protein and modulation of the quinoline heterocyclic region by structure based design and modeling allowed for the optimization of enzyme potency and cellular activity. This research led to the selection of clinical candidate IDX320 having good genotype coverage and pharmacokinetic properties in various species. (C) 2015 Elsevier Ltd. All rights reserved.